Recent robust data demonstrating the role of leptin, IGF-1, adipocytokines, and obesity-related hormones in the pathology of breast cancer has clarified the possibility of disease prevention through lifestyle alteration and specific signaling-targeted inhibition [287,292]. This evidence concerns the gene LEP and breast cancer.